lifestyle.thedishh.com

Author: AlzeCure Pharma

AlzeCure Pharma to Present at Stora Aktiedagarna in Stockholm on March 11

March 4, 2026
AlzeCure Publishes its Year-End Report for January – December 2025

February 26, 2026
Pain Project ACD440 Granted Orphan Drug Status in the EU

February 24, 2026
AlzeCure Abstract on NeuroRestore ACD856 accepted at the Alzheimer’s conference AP/PD 2026

February 7, 2026
AlzeCure Pharma Selected to Present at the Bio-Neuroscience conference in Amsterdam

February 7, 2026